Home › Amyloidosis › Minnesota
Amyloidosis clinical trials in Minnesota
10 studies for Amyloidosis are looking for participants at sites in Minnesota.
Cities in Minnesota
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Rochester
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Rochester
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Rochester
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 15, 2026 · NCT07223203Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Mayo Clinic - Rochester, Rochester
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
- GSK Investigational Site, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 17, 2026 · NCT07224672A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07081646A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Mayo Clinic - Rochester /ID# 255258, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT06158854MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Mayo Clinic, Rochester
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 20 and older · All sexes · Updated Dec 26, 2025 · NCT07216469A Study Of MCG In Cardiac Amyloidosis
- Mayo Clinic in Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 22, 2025 · NCT07218705From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.